BioCentury | Apr 15, 2013
Clinical News

Zintevir integrase inhibitor data

...the company said. Zintevir is in Phase I/II testing, with completion expected early in 1998. Aronex Pharmaceuticals Inc....
BioCentury | Feb 21, 2005
Product Development

New focus on HIV pipeline

...companies have tried to target integrase to no avail, according to MRK's Shiver. For example, Aronex Pharmaceuticals Inc....
BioCentury | Jul 19, 2004
Product Development

Cancer test bed

...tretinoin, an injectable liposomal all-trans retinoic acid, which the company obtained through its acquisition of Aronex Pharmaceuticals Inc....
BioCentury | Jun 24, 2002
Company News

Aronex other research news

...immune responses that are important for clearing small numbers of residual tumor cells after chemotherapy. Aronex Pharmaceuticals Inc....
BioCentury | Dec 10, 2001
Company News

Dyax management update

...SVP of medical affairs and clinical operations, formerly CMO and VP for medical affairs at Aronex Pharmaceuticals Inc....
BioCentury | Oct 22, 2001
Company News

NewBiotics management update

...Cossum as EVP of drug development, formerly VP of preclinical R&D and business development at Aronex Pharmaceuticals Inc. WIR...
BioCentury | Aug 13, 2001
Company News

Tanox Corp. management update

...Seenu Srinivasan as VP of manufacturing operations, formerly VP of pharmaceutical development and operations at Aronex Pharmaceuticals Inc. WIR...
BioCentury | Jul 23, 2001
Company News

Genzyme Transgenics management update

...Cardiovascular Hired: Geoffrey Cox, a director, as chairman and CEO, formerly chairman and CEO of Aronex Pharmaceuticals Inc....
BioCentury | Jul 19, 2001
Company News

Cox to head Genzyme Transgenics

...chairman James Geraghty will remain a director. Most recently, Cox was chairman and CEO of Aronex...
BioCentury | Jul 16, 2001
Company News

Antigenics, Aronex deal

...an additional $0.15 per ARNX share based on contingencies. Antigenics Inc. (AGEN), New York, N.Y. Aronex Pharmaceuticals Inc....
Items per page:
1 - 10 of 134
BioCentury | Apr 15, 2013
Clinical News

Zintevir integrase inhibitor data

...the company said. Zintevir is in Phase I/II testing, with completion expected early in 1998. Aronex Pharmaceuticals Inc....
BioCentury | Feb 21, 2005
Product Development

New focus on HIV pipeline

...companies have tried to target integrase to no avail, according to MRK's Shiver. For example, Aronex Pharmaceuticals Inc....
BioCentury | Jul 19, 2004
Product Development

Cancer test bed

...tretinoin, an injectable liposomal all-trans retinoic acid, which the company obtained through its acquisition of Aronex Pharmaceuticals Inc....
BioCentury | Jun 24, 2002
Company News

Aronex other research news

...immune responses that are important for clearing small numbers of residual tumor cells after chemotherapy. Aronex Pharmaceuticals Inc....
BioCentury | Dec 10, 2001
Company News

Dyax management update

...SVP of medical affairs and clinical operations, formerly CMO and VP for medical affairs at Aronex Pharmaceuticals Inc....
BioCentury | Oct 22, 2001
Company News

NewBiotics management update

...Cossum as EVP of drug development, formerly VP of preclinical R&D and business development at Aronex Pharmaceuticals Inc. WIR...
BioCentury | Aug 13, 2001
Company News

Tanox Corp. management update

...Seenu Srinivasan as VP of manufacturing operations, formerly VP of pharmaceutical development and operations at Aronex Pharmaceuticals Inc. WIR...
BioCentury | Jul 23, 2001
Company News

Genzyme Transgenics management update

...Cardiovascular Hired: Geoffrey Cox, a director, as chairman and CEO, formerly chairman and CEO of Aronex Pharmaceuticals Inc....
BioCentury | Jul 19, 2001
Company News

Cox to head Genzyme Transgenics

...chairman James Geraghty will remain a director. Most recently, Cox was chairman and CEO of Aronex...
BioCentury | Jul 16, 2001
Company News

Antigenics, Aronex deal

...an additional $0.15 per ARNX share based on contingencies. Antigenics Inc. (AGEN), New York, N.Y. Aronex Pharmaceuticals Inc....
Items per page:
1 - 10 of 134